UNSPSC 51170000: Drugs affecting the gastrointestinal system

This classification denotes drugs that act on the digestive structures stretching from the mouth to anus, but does not include the accessory glandular organs.

UNSPSC 51170000 Drugs affecting the gastrointestinal system is a Family code that encompasses pharmaceutical products and related supplies state and local governments procure for emergency medical services, forensic laboratory operations, community health initiatives, and employee wellness programs. Recent solicitations show a diverse mix of gastrointestinal and opioid-related medications alongside broader pharmaceutical procurement — the City of Tucson Fire Department's RFP for BLS/ALS pharmaceuticals and supplies (posted June 24, 2026, RFP 260217), Seminole County's IFB for naloxone and drug deactivation systems (posted June 30, 2026, IFB 60459723LAS), and the Minnesota Multistate Cooperative Purchasing Alliance's RFP for generic multi-source pharmaceuticals and OTC products (posted January 20, 2026, RFP S1070000015802) illustrate the scope. State health departments, county procurement offices, fire departments, and cooperative purchasing vehicles—including MMCAP, which spans multiple states and local jurisdictions—issue solicitations under this code. County governments and municipal fire departments appear as repeat buyers, often procuring emergency response supplies, while state-level cooperative purchasing vehicles consolidate demand across multiple jurisdictions.

Activity under the code concentrates in Florida, Arizona, and multi-state cooperative arrangements. Tucson's procurement (Arizona) required 251 line items of pharmaceuticals, supplies, and equipment with estimated annual usage ranging from 1 to 120,000 units per item, delivered to multiple fire stations with a 95 percent fill-rate requirement and two-year expiration dates on at least 75 percent of delivered products. Seminole County (Florida) sought 1,900 units of naloxone and 800 drug deactivation systems annually with quarterly deliveries, fixed unit pricing, and a two-year initial term. MMCAP's cooperative RFP targets generic pharmaceuticals and OTC products through authorized wholesalers—AmerisourceBergen (Cencora), Cardinal Health, and Morris & Dickson—for distribution across state and local facilities in Minnesota, Oregon, and other participating jurisdictions, with proposals due March 26, 2026, pricing weighted at 75 percent of evaluation, and a July 1, 2026 effective date for awarded contracts. Tucson's solicitation included federal funding through ARPA, HUD, and FTA with prevailing wage and Davis-Bacon obligations; Seminole County indicated potential FEMA funding. Most procurements require pharmacy licensing, FDA and DEA compliance, Drug Supply Chain Security Act certification, and E-Verify verification.